Impact of carotid atherosclerosis in CHA2DS2-VASc-based risk score on predicting ischemic stroke in patients with atrial fibrillation

被引:7
|
作者
Cho, Dong-Hyuk [1 ,3 ]
Choi, Jong-Il [1 ]
Choi, Jimi [2 ]
Kim, Yun Gi [1 ]
Oh, Suk-Kyu [1 ]
Kook, Hyungdon [1 ]
Lee, Kwang No [1 ]
Shim, Jaemin [1 ]
Park, Seong-Mi [1 ]
Shim, Wan Joo [1 ]
Kim, Young-Hoon [1 ]
机构
[1] Korea Univ, Dept Internal Med, Div Cardiol, Med Ctr, 73 Inchon Ro, Seoul 02841, South Korea
[2] Korea Univ, Dept Biostat, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Dept Internal Med, Div Cardiol, Wonju Coll Med, Wonju, South Korea
基金
新加坡国家研究基金会;
关键词
Atrial fibrillation; Stroke; Carotid stenosis Carotid intima media thickness; Risk assessment; INTIMA-MEDIA THICKNESS; AMERICAN SOCIETY; DIASTOLIC DYSFUNCTION; EUROPEAN ASSOCIATION; ECHOCARDIOGRAPHY; DISEASE; ARTERY; THROMBOEMBOLISM; RECOMMENDATIONS; COMPLICATIONS;
D O I
10.3904/kjim.2019.099
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Vascular disease is an established risk factor for stroke in patients with atrial fibrillation (AF), which is included in CHA(2)DS(2)-VASc score. However, the role of carotid atherosclerosis remains to be determined. Methods: Three hundred-ten patients with AF who underwent carotid sonography were enrolled. Results: During a median follow-up of 31 months, 18 events (5.8%) of stroke were identified. Patients with stroke had higher carotid intima-media thickness (CIMT) (1.16 +/- 0.33 mm vs. 0.98 +/- 0.25 mm, p = 0.017). CIMT was significantly increased according to the CHA(2)DS(2)-VASc score (p < 0.001) and it was correlated with left ventricular mass index and early diastolic mitral annular velocity (e'), a ratio of early transmitral flow velocity to e' (E/e') and pulmonary artery systolic pressure (all p < 0.05). Cox regression using multivariate models showed that carotid plaque was associated with the risk of stroke (hazard ratio, 3.748; 95% confidence interval [CI], 1.107 to 12.688; p = 0.034). C-statistics increased from 0.648 (95% CI, 0.538 to 0.757) to 0.716 (95% CI, 0.628 to 0.804) in the CHA(2)DS(2)-VASc score model after the addition of CIMT and carotid plaque as a vascular component (p = 0.013). Conclusions: Increased CIMT and presence of carotid plaque are associated with a high risk of ischemic stroke, and CIMT is related to myocardial remodeling and diastolic dysfunction, suggesting that carotid atherosclerosis can improve risk prediction of stroke in patients with AF, when included under vascular disease in the CHA(2)DS(2)-VASc scoring system.
引用
收藏
页码:342 / 351
页数:10
相关论文
共 50 条
  • [21] CHA2DS2-VASc Score and Stroke Prediction in Atrial Fibrillation in Whites, Blacks, and Hispanics
    Chen, Lin Y.
    Norby, Faye L.
    Chamberlain, Alanna M.
    MacLehose, Richard F.
    Bengtson, Lindsay G. S.
    Lutsey, Pamela L.
    Alonso, Alvaro
    STROKE, 2019, 50 (01) : 28 - 33
  • [22] CHA2DS2-VASc Score Is Associated With Prognosis in Patients With Acute Ischemic Stroke Without Atrial Fibrillation
    Song, Mingjuan
    Chen, Xu
    TEXAS HEART INSTITUTE JOURNAL, 2025, 52 (01)
  • [23] Atrial Fibrillation in Adult Congenital Heart Increase Ischemic Stroke Risk Even at Low CHA2DS2-VASc Score
    Lin, Yu-Sheng
    Huang, Yi-Chun
    Lin, Chia -Pin
    Wu, Victor Chien -Chia
    Kao, Yi-Wei
    Chiang, Hou-Yu
    Chu, Pao-Hsien
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2023, 24 (08)
  • [24] Impact of the CHA2DS2-VASc Score on Anticoagulation Recommendations for Atrial Fibrillation
    Mason, Pamela K.
    Lake, Douglas E.
    DiMarco, John P.
    Ferguson, John D.
    Mangrum, J. Michael
    Bilchick, Kenneth
    Moorman, Liza P.
    Moorman, J. Randall
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (06) : 603.e1 - 603.e6
  • [25] CHA2DS2-VASc score and prognosis in ischemic strokes with atrial fibrillation
    Eva Giralt-Steinhauer
    Elisa Cuadrado-Godia
    Ángel Ois
    Jordi Jiménez-Conde
    Ana Rodríguez-Campello
    Lluis Planellas
    Sara Jimena-García
    Miguel Ángel Rubio
    Jaume Roquer-González
    Journal of Neurology, 2012, 259 : 745 - 751
  • [26] Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation
    Pieri, Alexandre
    Lopes, Tania Oliveira
    Gabbai, Alberto Alain
    INTERNATIONAL JOURNAL OF STROKE, 2011, 6 (05) : 466 - 466
  • [27] Impact of timing of atrial fibrillation, CHA2DS2-VASc score and cancer therapeutics on mortality in oncology patients
    Hussain, Muzna
    Misbah, Rabel
    Donnellan, Eoin
    Alkharabsheh, Saqer
    Hou, Yuan
    Cheng, Feixiong
    Crookshanks, Michael
    Watson, Chris J.
    Toth, Andrew J.
    Houghtaling, Penny
    Moudgil, Rohit
    Budd, G. Thomas
    Tang, W. H. Wilson
    Kwon, Deborah H.
    Jaber, Wael
    Griffin, Brian
    Kanj, Mohamad
    Collier, Patrick
    OPEN HEART, 2020, 7 (02):
  • [28] Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study
    Yoon, Minjae
    Yang, Pil-Sung
    Jang, Eunsun
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Jong-Youn
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Lip, Gregory Y. H.
    Joung, Boyoung
    THROMBOSIS AND HAEMOSTASIS, 2018, 118 (07) : 1296 - 1304
  • [29] Carotid plaque detection improves the predictive value of CHA2DS2-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study
    Basili, Stefania
    Loffredo, Lorenzo
    Pastori, Daniele
    Proietti, Marco
    Farcomeni, Alessio
    Vestri, Anna Rita
    Pignatelli, Pasquale
    Davi, Giovanni
    Hiatt, William R.
    Lip, Gregory Y. H.
    Corazza, Gino R.
    Perticone, Francesco
    Violi, Francesco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 231 : 143 - 149
  • [30] CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation
    Semczuk-Kaczmarek, Karolina
    Platek, Anna E.
    Rys, Anna
    Adamowicz, Jakub
    Legosz, Pawel
    Kotkowski, Marcin
    Dudzik-Plocica, Alicja
    Gorko, Dariusz
    Szymanski, Filip M.
    Filipiak, Krzysztof J.
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (11): : 1451 - 1457